Literature DB >> 29887026

Efficacy of afoxolaner in the treatment of otodectic mange in naturally infested cats.

Marília Alves Machado1, Diefrey Ribeiro Campos2, Natália Lôres Lopes3, Isabela Pessôa Barbieri Bastos4, Cristiane Bazaga Botelho5, Thais Ribeiro Correia6, Fábio Barbour Scott7, Julio Israel Fernandes8.   

Abstract

Afoxolaner is a drug belonging to the isoxazolines' family, and it is recommended for ectoparasite control in dogs. The objective of this study was to evaluate the efficacy of afoxolaner in the treatment of otodectic mange in naturally infested cats. Sixteen cats were divided into two groups (treated and control). The treated group (n = 8) underwent a single oral presentation of afoxolaner at a dose of 2.5 mg/kg. The control group (n = 8) received no antiparasitic treatment. The detection of mite infestations were performed by video otoscopy before the medication, 48 h after the medication and at weekly intervals up to 35 days after treatment (+7, +14, +21, +28, +35). In the treated group, the animals were negative for the presence of the mite 48 h after the medication and throughout the evaluation period. The control group remained positive throughout the experiment, demonstrating 100% efficacy (p < 0.05) for the treated cats naturally infested with Otodectes cynotis in a single dose over a period of 35 days. The animals were reintroduced into their natural habitat, allowed to regain contact with other cats and then reassessed for possible reinfestation. It was found that afoxolaner was effective in the treatment of otodectic mange the animals presented no adverse reaction to the use of afoxolaner.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antiparasitic; Control; Isoxazolines; Otoacariasis; Otodectes cynotis

Mesh:

Substances:

Year:  2018        PMID: 29887026     DOI: 10.1016/j.vetpar.2018.04.013

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  5 in total

1.  Efficacy of a novel topical combination of esafoxolaner, eprinomectin and praziquantel against ear mite (Otodectes cynotis) infestations in cats.

Authors:  Eric Tielemans; Joe Prullage; Otsuki Tomoko; Julian Liebenberg; Balázs Capári; Smaragda Sotiraki; Despoina Kostopoulou; Panagiota Ligda; Michael Ulrich; Martin Knaus
Journal:  Parasite       Date:  2021-04-02       Impact factor: 3.000

2.  Pharmacokinetics of a novel endectoparasiticide topical formulation for cats, combining esafoxolaner, eprinomectin and praziquantel.

Authors:  Virginie Jacquot; Prescillia Buellet; Laura Letendre; Wei Tong; Henry Li; Eric Tielemans
Journal:  Parasite       Date:  2021-04-02       Impact factor: 3.000

3.  Efficacy of fluralaner plus moxidectin (Bravecto® Plus spot-on solution for cats) against Otodectes cynotis infestations in cats.

Authors:  Janina Taenzler; Christa de Vos; Rainer K A Roepke; Anja R Heckeroth
Journal:  Parasit Vectors       Date:  2018-11-19       Impact factor: 3.876

4.  Efficacy of Oral Sarolaner for the Treatment of Feline Otodectic Mange.

Authors:  Diefrey Ribeiro Campos; Jéssica Karoline de Oliveira Chaves; Brena Gava Guimarães; So Yin Nak; Gabriela Pereira Salça de Almeida; Isabela Scalioni Gijsen; Juliana de Moraes Intrieri; Fabio Barbour Scott
Journal:  Pathogens       Date:  2021-03-15

5.  Effectiveness of a fluralaner spot-on formulation in a case of feline demodicosis due to Demodex cati.

Authors:  Pavlina Bouza-Rapti; Anatoli Tachmazidou; Rania Farmaki
Journal:  JFMS Open Rep       Date:  2022-01-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.